134 related articles for article (PubMed ID: 25936796)
21. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapeutic alteration of VEGF, PDGF and PDGFRα/β expression under 5-FU vs. docetaxel in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
Aderhold C; Umbreit C; Faber A; Sauter A; Sommer JU; Birk R; Erben P; Hofheinz RD; Stern-Straeter J; Hörmann K; Schultz JD
Anticancer Res; 2013 May; 33(5):1951-61. PubMed ID: 23645743
[TBL] [Abstract][Full Text] [Related]
23. trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells.
Cao Z; Fang J; Xia C; Shi X; Jiang BH
Clin Cancer Res; 2004 Aug; 10(15):5253-63. PubMed ID: 15297429
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol induces cell-cycle disruption and apoptosis in chemoresistant B16 melanoma.
Gatouillat G; Balasse E; Joseph-Pietras D; Morjani H; Madoulet C
J Cell Biochem; 2010 Jul; 110(4):893-902. PubMed ID: 20564188
[TBL] [Abstract][Full Text] [Related]
25. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
[TBL] [Abstract][Full Text] [Related]
26. Dipyridamole augments the antitumor effects of fluorinated pyrimidines.
Sakaguchi Y; Kusumoto T; Kusumoto H; Maehara Y; Furusawa M; Sugimachi K
Anticancer Res; 1992; 12(1):119-21. PubMed ID: 1567156
[TBL] [Abstract][Full Text] [Related]
27. Combinational therapy of interferon-α and chemotherapy normalizes tumor vasculature by regulating pericytes including the novel marker RGS5 in melanoma.
Liu P; Zhang C; Chen J; Zhang R; Ren J; Huang Y; Zhu F; Li Z; Wu G
J Immunother; 2011 Apr; 34(3):320-6. PubMed ID: 21389866
[TBL] [Abstract][Full Text] [Related]
28. PTK787/ZK222584 combined with interferon alpha and 5-fluorouracil synergistically inhibits VEGF signaling pathway in hepatocellular carcinoma.
Katsura Y; Wada H; Murakami M; Akita H; Hama N; Kawamoto K; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S517-26. PubMed ID: 23508585
[TBL] [Abstract][Full Text] [Related]
29. Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro.
Hamsa TP; Kuttan G
Eur J Pharmacol; 2010 Dec; 649(1-3):64-73. PubMed ID: 20858484
[TBL] [Abstract][Full Text] [Related]
30. Impact of acetylsalicylic acid on tumor angiogenesis and lymphangiogenesis through inhibition of VEGF signaling in a murine sarcoma model.
Zhang X; Wang Z; Wang Z; Zhang Y; Jia Q; Wu L; Zhang W
Oncol Rep; 2013 May; 29(5):1907-13. PubMed ID: 23483185
[TBL] [Abstract][Full Text] [Related]
31. The prednisolone phosphate‑induced suppression of the angiogenic function of tumor‑associated macrophages enhances the antitumor effects of doxorubicin on B16.F10 murine melanoma cells in vitro.
Licarete E; Rauca VF; Luput L; Patras L; Sesarman A; Banciu M
Oncol Rep; 2019 Dec; 42(6):2694-2705. PubMed ID: 31578578
[TBL] [Abstract][Full Text] [Related]
32. DCA increases the antitumor effects of capecitabine in a mouse B16 melanoma allograft and a human non-small cell lung cancer A549 xenograft.
Zheng MF; Shen SY; Huang WD
Cancer Chemother Pharmacol; 2013 Nov; 72(5):1031-41. PubMed ID: 24043136
[TBL] [Abstract][Full Text] [Related]
33. A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo.
Rastelli L; Valentino ML; Minderman MC; Landin J; Malyankar UM; Lescoe MK; Kitson R; Brunson K; Souan L; Forenza S; Goldfarb RH; Rabbani SA
Int J Oncol; 2011 Aug; 39(2):401-8. PubMed ID: 21567086
[TBL] [Abstract][Full Text] [Related]
34. [Inhibitory Effect of Ginsenoside Rg3 Combined With 5-Fluorouracil on Tumor Angiogenesis and Tumor Growth of Colon Cancer in Mice: An Experimental Study].
Zhao Y; Deng L; Cao Y; Ma B; Li Y; Xu J; Li H; Huang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 55(1):111-117. PubMed ID: 38322531
[TBL] [Abstract][Full Text] [Related]
35. Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture.
Trapp V; Parmakhtiar B; Papazian V; Willmott L; Fruehauf JP
Angiogenesis; 2010 Dec; 13(4):305-15. PubMed ID: 20927579
[TBL] [Abstract][Full Text] [Related]
36. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
[TBL] [Abstract][Full Text] [Related]
37. Establishment of a quantitative mouse dorsal air sac model and its application to evaluate a new angiogenesis inhibitor.
Funahashi Y; Wakabayashi T; Semba T; Sonoda J; Kitoh K; Yoshimatsu K
Oncol Res; 1999; 11(7):319-29. PubMed ID: 10757446
[TBL] [Abstract][Full Text] [Related]
38. Ligustrazine inhibits B16F10 melanoma metastasis and suppresses angiogenesis induced by Vascular Endothelial Growth Factor.
Chen L; Lu Y; Wu JM; Xu B; Zhang LJ; Gao M; Zheng SZ; Wang AY; Zhang CB; Zhang WW; Lei N
Biochem Biophys Res Commun; 2009 Aug; 386(2):374-9. PubMed ID: 19523924
[TBL] [Abstract][Full Text] [Related]
39. Resveratrol derivative-rich melinjo (Gnetum gnemon L.) seed extract suppresses multiple angiogenesis-related endothelial cell functions and tumor angiogenesis.
Kunimasa K; Ohta T; Tani H; Kato E; Eguchi R; Kaji K; Ikeda K; Mori H; Mori M; Tatefuji T; Yamori Y
Mol Nutr Food Res; 2011 Nov; 55(11):1730-4. PubMed ID: 21936049
[TBL] [Abstract][Full Text] [Related]
40. Determinants for in vivo antitumor effect of angiogenesis inhibitor SU5416 formulated in PEGylated emulsion.
Ogawara K; Abe S; Un K; Yoshizawa Y; Kimura T; Higaki K
J Pharm Sci; 2014 Aug; 103(8):2464-9. PubMed ID: 24985750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
